Lupin shares bounce back 10.5% in one month; should investors jump on the bandwagon?

Opinion is split, but most analysts recommend waiting for more clarity from Lupin.

Related Keywords

Nagpur ,Maharashtra ,India , ,Drug Administration ,Nifty Pharma ,Vineet Gala ,Xylem Investment Managers ,Lupin ,Dharma ,Pharmaceuticals ,Pharma Sector ,Ps Generic ,Spiriva ,S Market ,Drugmaker ,Investment Ideas ,